Previous analysis of the class 1 outer-membrane (OM) protein of Neisseria meningitidis has identified discrete epitopes to be potential targets for immune attack. The conformation of these epitopes is important for inducing 'n, Southampton, SO18 6YD, UK antibodies which can react with the native protein and promote complementmediated lysis of the meningococcus. The multiple antigen peptide (MAP) system, which consists of an oligomeric branching lysine core to which are attached dendritic arms of defined peptide antigens, confers some conformational stability and also allows for the preparation of immunogens containing both B-cell and T helper (Th)-cell epitopes. In this study, MAPS were synthesized to contain (i) the subtype P1.16b meningococcal class 1 protein Bcell epitope (B-MAP), and (ii) the P1.16b epitope in tandem with a defined Thcell epitope, chosen from tetanus toxin (BT-MAP). The B-MAP was nonimmunogenic in animals. In contrast, incorporation of the Th-cell epitope into BT-MAP induced a strong humoral response towards the class 1 protein B-cell epitope. Antisera from immunized mice and rabbits reacted in ELISA with synthetic peptides containing the B-cell epitope, and also cross-reacted with meningococcal OMS from strains of subtype P1.16b and P1.16a. Murine and rabbit antisera showed similar reactivity and epitope specificity, but did not react with denatured class 1 protein in Western blotting, indicating the predominance of antibodies directed towards conformational epitopes. The antisera from rabbits immunized with BT-MAP promoted complementmediated bactericidal killing not only of the homologous meningococcal subtype P1.16b strain but also of subtype P1.16a.
INTRODUCTION
The lack of an effective vaccine remains a major obstacle in the prevention of life threatening meningitis and septicaemia caused by Neisseria meningitidis. The vaccines currently in use are based on the meningococcal serogroup-specific capsular polysaccharides, and are of limited efficacy. The capsular polysaccharides from serogroups A and C provide only short-term protection in adults, because of their inability to induce a T helper (Th)-cell Abbreviations: mAb, monoclonal antibody; MAP, multiple antigen peptide; OM, outer membrane; Th-cell, T helper-cell.
response and hence immunological memory (Frasch, 1985) . In addition they are non-immunogenic in infants, the age group at greatest risk of infection. Furthermore, the group B capsular polysaccharide is non-immunogenic even in adults, so that current vaccines provide no protection against group B strains, the predominant cause of infection in most temperate countries.
Currently, new experimental vaccines based on outermembrane (OM) preparations are under investigation. This strategy is based on the observations that the presence of serum bactericidal activity in humans correlates with immunity to infection (Goldschneider e t al., 1969) and that antibodies directed against meningococcal O M proteins activate complement and kill encapsulated strains (Frasch, 1985) . Recent field trials with vaccines based on OM preparations have demonstrated some protection against group B infection (Bjune e t al., 1991 ; de Moraes et al., 1992) . However the duration of protection appeared to be relatively short-lived (Bjune et al., 1991) and, in addition, at least one study concluded that immunization induced a high proportion of nonfunctional antibodies, as measured by bactericidal activity (Zollinger e t al., 1991) . Improved vaccines should therefore be achieved by simultaneously targeting the immune response to specific epitopes on OM proteins known to induce bactericidal antibodies and by prolonging the duration of the effective immune response.
Four major classes of meningococcal OM proteins have been identified (Tsai et al., 198l) , of which the class 1 protein is an attractive potential target for immune attack. Unlike several other meningococcal major surface antigens the class 1 protein does not undergo antigenic variation within a strain, and is responsible for serosubtype specificity (Frasch et al., 1985) . Subtype-specific monoclonal antibodies (mAbs) are bactericidal and are particularly effective in preventing infection in the infant rat model of meningococcal infection (Saukkonen e t al., 1989) . Bactericidal activity in sera from human volunteers immunized with experimental OM protein vaccines appears, in part, to be associated with the production of anti-class 1 antibodies (Wedege & Froholm, 1986 ; Zollinger e t al., 1991) . The cloning and sequencing of the p o r A genes which encode the class 1 protein has permitted detailed structural and antigenic studies which have led to a model of the organization of the protein within the outer membrane (van der Ley e t al., 1991) . The model predicts that a series of conserved regions form amphipathic transmembrane @-sheets, so generating eight surfaceexposed hydrophilic loops. Structural variations between strains are largely confined to two variable regions VR1 and VR2 which are located in the surface-exposed loops 1 and 4 (McGuinness et al., 1990) . Epitope mapping with synthetic peptides has localized the epitopes recognized by the bactericidal, subtype-specific mAbs to the apices of these loops (McGuinness e t al., 1990 (McGuinness e t al., , 1993 . Thus a mAb with Pl.16a subtype specificity reacted with the peptide TKDTNNNLTL, located at the apex of loop 4. The critical contribution of this region is further demonstrated by the observation that a single amino acid substitution from D to N at position 182 within the epitope results in the generation of a class 1 protein with altered antigenic properties (subtype P1.16b) (McGuinness e t al., 1991) .
Such detailed antigenic analysis has identified discrete regions of the class 1 protein to be potential targets for immune attack. In a previous study with synthetic linear and cyclic peptides, a cyclic 36mer peptide containing the P1.16b subtype epitope was shown to induce conformationally relevant antibodies which promoted complementmediated bactericidal killing of the homologous meningococcal strain (Christodoulides e t al., 1993) . However, the synthesis of conformationally constrained peptides to accurately mimic the three-dimensional structure of the native protein is technically demanding and difficult to monitor. In this report, an alternative approach has been the use of multiple antigen peptides (MAPs), consisting of an oligomeric branching lysine core, to which are attached dendritic arms of defined peptide antigens (Tam, 1988) . Consequently, the overall structure of a MAP is of a macromolecule with a high density of surface peptide antigens surrounding a non-immunogenic core matrix of low molecular mass. The high density of peptide antigens seems to enhance the immunogenicity that is often absent when a single copy of the same peptide antigen is used (Francis et al., 1991) . Also, because of the close packing of these dendritic antigens in the macromolecular structure, MAPs may have the advantage of providing a tertiary structure that allows some conformational stability to the peptides (DeFoort e t al., 1992a). The system also allows the preparation of immunogens consisting of both B-cell and T-cell epitopes in various arrangements.
In this report, peptides containing the meningococcal Bcell epitope TKNTNNNLTL have been synthesized on MAPs with and without a tandem Th-cell epitope, and investigated as experimental peptide vaccines, with respect to their immunogenicity and the antigenic and biological activities of the antibodies induced.
METHODS
Bacterial strains and growth conditions. Neisseria meningitidis strains MC50 (C:NT:Pl.lba), MC58 (B: 15:P1.7,16b) and MC51 (C: N T : P1-15) have been described previously (Tinsley & Heckels, 1986) . Strain H44/76 (B: 15:Pla7,16a) is the subtype P1.7,16 reference strain (Frasch et a/., 1985) . All strains were grown on protease-peptone agar at 37 OC for 18 h in an atmosphere of 5 % (v/v) CO, (Tinsley & Heckels, 1986) .
Outer membranes. Outer membranes were prepared by extraction of whole cells with lithium acetate as described previously (Tinsley & Heckels, 1986 ).
Solid-phase peptide synthesis. Peptides (Table 1) were synthesized using solid-phase Fmoc [ N-a-(9-fluorenylmethoxycarbonyl)] chemistry, on an Applied Biosystems Model 431A Peptide Synthesizer, as described previously (Christodoulides e t a/., 1993). For MAP synthesis, 4-or 8-branch MAP cores with Fmoc protection were obtained from Applied Biosystems Inc. (ABI) and coupled to 4-(hydroxymethy1)-phenoxymethyl (HMP) copolystyrene-1 ' / o divinylbenzene resin (ABI). Linear peptides were also synthesized on HMP resin. Synthesis of both linear and MAP peptides used Fmoc-protected amino acids with t-butyl side chain protecting groups, with the exception of asparagine (trityl-) and lysine (Boc). Activation and coupling was done in the presence of hydroxybenzotriazole/ dicyclohe-\ylcarbodiimide and at the completion of synthesis all peptides were acetylated at the N terminus with acetic anhydride.
Crude peptides were washed with ether and purified by reversephase H P I L on a semi-preparative Zorbax C8 (DuPont) column using a gradient of 5-80 YO (v/v) acetonitrile in water containing 0.1 YO TF '2, as described previously (Christodoulides et al., 1993) . Purified peptides were obtained as single peaks in > 95 Yo yield, and were lyophilized and stored desiccated at -20 "C. The expected amino acid composition of each peptide was verified h y amino acid analysis using an automated analyser (ABI).
Multiple solid-phase synthesis and epitope mapping. Multiple solid-phase peptides were synthesized by pin technology u\ing a commercially available kit (Chiron Mimotopes) according to the manufacturer's instructions. The solid phase supports were polyethylene pins, each of which had a Fmoc-protected p-alanine residue coupled via a flexible linker of 1,6-diaminohexane and polyacrylic acid (Geysen e t al., 1987) . S! nthesis used pentafluorophenyl (pfp)-activated esters of Fmoc--L-amino acids with t-butyl side-chain protection (Milligen), except for arginine (methoxytrimethylphenylsulphon:, 1 side-chain) and serine and threonine which were used as oxabenzotriazine active esters. After synthesis, the terminal amino acid group was acetylated and the side-chain protecting groups removed as described previously (Virji & Heckels, 1989) . O n each occasion, peptide controls were synthesized and reacted nrith mAb SM300 which recognizes sequence TKDTNNNLTL, but not TKNTNNNLTL (McGuinness et a/., 1993). The pins were used for epitope mapping of sera as described previously (Christodoulides et al. , 1993).
Immunization of animals. Female Balb/C (H-2d) mice of 6-7 weeks of age, and New Zealand half-lop rabbits were used for immunizations. Mice were housed 10 to a cage, from which five were chosen at random and each immunized intraperitoneally on day 1 with 25 pg of peptide emulsified in Freund's complete adjuvant (Sigma) and on days 14 and 28 with the same peptide emulsified in Freund's incomplete adjuvant (Sigma). The remaining five mice were unimmunized controls, which were bled at the same time as immunized animals. Rabbits (two per immunogen) were each immunized subcutaneously on day 1 with 25 pg of peptide emulsified in Freund's complete adjuvant distributed between two and three sites, and on days 14 and 28 with the same peptide emulsified in Freund's incomplete adjuvant.
Test bleeds were taken from all animals 10 d after the second booster immunization, to monitor levels of circulating antipeptide antibodies by ELISA. Up to a further two booster immunizations were then given, after which all animals were terminally bled by cardiac puncture under anaesthesia. All sera were stored at -20 "C.
Detection of immune response. (i)
ELISA. ELISA determination of antibody was done as described previously (Christodoulides et al., 1993) . Flat-bottomed microtitre plates (Sterilin) were coated overnight at 37 "C with antigen (1 pg ml-') in 0.05 M sodium carbonate buffer, pH 9.6. Antibody binding was detected using the appropriate horseradish peroxidase conjugate (Zymed) with 3,3',5,5'-tetramethylbenzidine and H,O, as enzyme substrate. Absorbance was measured at 450 nm and the ELISA titre was extrapolated from the linear portion of the serum titration curve and taken as the reciprocal dilution which gave an absorbance of 0.1 h-l.
(ii) Western immunoblotting. Meningococcal outer-membrane protein preparations were separated by preparative SDS-PAGE (250 pg total protein per gel), using a 10-25 YO (w/v) acrylamide gradient as described previously (Heckels, 1981) . Proteins were transferred to nitrocellulose paper (Schleicher and Schuell BA45, 0.45 pm) using a Trans-Blot Semi-Dry transfer cell (BioRad) as described previously (McGuinness e t al., 1993). After incubation with sera, immunological reactivity was detected with the appropriate alkaline phosphatase conjugate (Zymed) and substrate solution containing nitroblue-tetrazolium and 5-bromo-4-chloro-3-indolylphosphate (Bio-Rad), as described previously (Christodoulides e t al., 1993).
Bactericidal killing assays. The bactericidal activity of antisera was determined essentially as described by Munkley e t al. (1991) using guinea-pig serum as a source of exogenous complement. Meningococcal strains MC58 or MC50 were harvested into PBSB containing 1 O h (v/v) heat-inactivated (56 "C, 30 min) foetal calf serum. Bacterial suspension (25 pl, containing approximately 1000 c.f.u.) was added to the wells of a sterile 96-well microtitre plate containing serial dilutions of decomplemented test sera in PBSB (10 pl). Freshly thawed complement or decomplemented serum was then added to a final concentration of 5 % (v/v) and the plates were agitated briefly to mix thoroughly. The plates were incubated at 37 OC for 30 min in an atmosphere of 5 Yo (v/v) CO,, and then 15 pl samples were removed from each well for determination of surviving c.f.u. All sera, with and without exogenous complement, were assayed in triplicate at each serial dilution, and the assays performed in triplicate. As positive controls for bactericidal killing assays, a rabbit polyclonal antiserum raised to P1.16a O M was used with the Pl.16a strain (MC50), and similarly a rabbit polyclonal antiserum raised against P1.16b cyclic peptide (Christodoulides eta/., 1993) for the P1.16b strain (MC58). For the heterologous strain MC51, a P1-15 specific mAb (MN3C5C) was used. The 
RESULTS lmmunogenicity of synthetic peptides
Initially, mice and rabbits were immunized with a multiple antigen peptide (MAP) octamer containing the B-cell epitope TKNTNNNL (B-MAP) with triglycyl spacers at the C termini of the peptide chains to provide flexibility away from the lysine core (Fig. la) . The murine and rabbit
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_-antisera raised against this peptide were tested in ELISA.
In neither case was any reaction detected with the immunizing B-MAP or with the linear synthetic peptide (B) containing the same epitope (Figs 2a and 3a) .
Since the MAP containing the B-cell epitope only, was non-immunogenic, further peptides were synthesized to contain a defined Th-cell epitope ( 
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subtype P1.16a strains MC50 and H44/76 (fivefold rises) (Fig. 2c) . The murine antisera showed approximately tenfold rises in mean titre against OMS from both subtype P1.1Gb and P1.16a meningococci (Fig. 3c) . N o increase in titre was observed when either rabbit or murine antisera to BT and BT-MAP were reacted with O M from a meningococcal strain of unrelated serosubtype, MC51 (C:NT:Pl-15).
Epitope mapping of rabbit and murine anti-peptide antisera
To determine the epitope specificity of the antisera raised, all sera were reacted with overlapping decapeptides corresponding to the amino acid sequence of loop 4 of the class 1 O M protein which contained the B-cell epitope. Peptides were synthesized on polyethylene pins with adjacent peptides differing by a single residue and containing either the Nls2 or Dls2 residue corresponding to the Pl.16b and Pl.16a epitopes, respectively. As expected from the ELISA results, immunization of rabbits and mice with the non-immunogenic peptides B, T or B-MAP induced antisera which failed to react with any of the decapeptides constituting loop 4 of the class 1 O M protein (data not shown).
In contrast, the immunogenic peptides BT and BT-MAP induced antisera which reacted with a variety of the decapeptides. Rabbit (Fig. 4a) and murine (Fig. 4c ) antisera raised to peptide BT showed essentially similar patterns of reactivity, both reacting with the decapeptide sequence lsoTKXTNNNLTL1sg, where X is either N (the subtype P1.16b amino acid sequence) or D (the subtype P1.16a amino acid substitution). Equally, little difference was seen between rabbit and murine antisera raised against peptide BT-MAP. In this case, rabbit antisera reacted with peptides incorporating amino acid residues 174-1 99 from the class 1 protein, and was centred around the decapeptide seq.uence lsoTI<XTNNNLTL1sg (Fig. 4b) . Murine antisera reacted similarly, with peptides incorporating amino acid residues 175-189 (Fig. 4d) . In addition, both rabbit and murine antisera raised against BT-MAP also reacted with additional peptides from the N-terminus of the sequence (Figs 4b and 4d) .
Reactivity of rabbit and murine antisera on Western blots
The specificity of reactivity of all anti-peptide antisera was also determined by Western blotting against O M from meningococcal strains MC58 (P1 .16b) and MC50 (P1 .16a).
Neither rabbit nor murine antisera raised against the immunogenic peptides BT and BT-MAP reacted with the class 1 protein from the strains MC58 or MC50.
Bactericidal activity of rabbit and murine antisera
Rabbit and murine antisera raised against synthetic peptides were tested for their ability to promote complement-mediated bactericidal killing of meningococcal strains MC58 (P1.16b) and MC50 (P1.16a) using guinea- pig serum as a complement source. The rabbit antisera raised against peptides BT-MAP and BT both demonstrated bactericidal killing of meningococci. Antiserum raised against peptide BT was bactericidal for the homologous strain MC58 (P1.16b) with a 50 YO endpoint at a dilution of approximately 1 : 80 (Fig. 5a) , and also showed weaker, but significant ( P < 0.05) killing of the subtype Pl.16a strain MC50 at dilutions of 1 : 10 (25 YO) and 1 : 40 (16%) (Fig. 5b) .
Bactericidal activity was greatest in rabbit antisera raised against the BT-MAP peptide. This antiserum was highly bactericidal for the homologous subtype P1.16b strain MC58 with a 50 YO endpoint of approximately 1 : 320 (Fig.   5c ), and also showed significant ( P < 0-05) killing of the subtype Pl-lba strain MC50 at dilutions of 1 : 10 (44 %) and 1 : 40 (32 YO) (Fig. 5d) . The subtype specificity of the killing was demonstrated by the fact that sera raised against BT and BT-MAP did not promote complementmediated bactericidal killing of an unrelated strain, MC5 1 (C:NT:P1-15) (data not shown).
Immunization with a multiple antigen peptide
In contrast to the rabbit antisera, murine antisera raised to peptides BT and BT-MAP did not show any bactericidal activity (data not shown).
DISCUSSION
A model for the organization of the class 1 protein within the O M of N. meningitidis predicts that a series of conserved regions form amphipathic a-sheets, thus generating eight surface-exposed hydrophilic loops (van der Ley ef a/., 1991). The protective, subtype-specific epitopes have been mapped to the apices of loops 1 and 4, which are the most surface-exposed and accessible to immune surveillance. In a previous report (Christodoulides e t al., 1993), linear synthetic peptides corresponding to the apex of loop 4 containing the protective B-cell epitope, induced antisera which reacted poorly with native protein in OMS, and arere non-bactericidal. In contrast, antisera raised by immunization with a large 36mer cyclic peptide incorporating the B-cell epitope, showed bactericidal activity against meningococci. In solution, synthetic peptides are likely to adopt a wide range of conformations, only a fraction of which may be relevant to the stable conformations of the native protein (Arnon, 1991). The important difference between linear peptides and the cyclic peptide was that the latter appeared to induce antisera which recognized conformational determinants. Consequently, reconstruction of the protective epitopes which induce antibodies cross-reactive with the native protein and bactericidal for the meningococcus, must involve some stabilization of peptide conformation. The synthesis of cyclic peptides which mimic precisely the structure of the native antigenic determinant is timeconsuming and experimentally difficult to achieve, so that the possible use of cyclic peptides for human vaccines poses significant problems. An alternative method for preparing chemically-defined immunogens with conformational stability is the multiple antigen peptide (MAP) system (Tam & Lu, 1991) . The MAP system also provides a method for introducing defined Th-cell epitopes into the peptide immunogen. This obviates the need for covalent coupling of peptide B-cell epitopes to high molecular mass protein carriers such as keyhole limpet haemocyanin (KLH) to provide Th-cell activity. Furthermore, there are other major limitations associated with the conjugation of peptides to carrier proteins which the MAP system was designed to overcome. The peptide antigen represents only a minor fraction of the total molecular mass of the peptide-carrier protein conjugate, in contrast to the multiple copies of peptide assembled on the low molecular mass lysine core of a MAP. Also, the coupling procedures used in the production of peptidecarrier protein conjugates may alter the structural and immunogenic properties of the peptide. In addition, immunization with peptide-carrier protein conjugates may induce undesirable immune responses to carrier molecules and/or the cross-linking reagent. The MAP system, however, produces carrierless, chemically-defined peptide immunogens, and can be considered more likely candidates for human use. In fact, the MAP system has been used to prepare experimental peptide vaccines, many of which include Th-cell epitopes, against protozoa (Darcy e t al., 1992 ; Calvo-Calle e t al., 1993), schistosomes (Reynolds e t al., 1994) , chlamydia (Zhong e t al., 1993) , hepatitis B (Tam & Lu, 1989) and HIV (DeFoort et al., 1992b) .
Initially, an octameric MAP containing the meningococcal P1.16b B-cell epitope TKNTNNNLTL was found to be non-immunogenic in animals, highlighting the need for an effective Th-cell epitope to induce a humoral immune response. For the synthesis of a potential meningococcal MAP vaccine containing the B-cell epitope, use was made of a well-characterized ' universal ' human Th-cell epitope comprising amino acids 830-843 from tetanus toxin (Panina-Bordignon e t al., 1989) . This Th-cell epitope has also been used in a MAP to enhance the immunogenicity of malarial B-cell epitopes in mice (Valmori e t al., 1992) . The meningococcal MAP was synthesized with the B-cell epitope at the N terminus of the assembled chain and the Th-cell epitope proximal to the tetrameric lysine core, i.e. as BT-MAP (Fig. 1 b) . This configuration of peptide presentation has been shown to be the most immunogenic for a B-cell epitope component (Tam e t al., 1990) . Incorporation of the Th-cell epitope into peptides significantly enhanced the humoral response of immunized animals towards the meningococcal B-cell epitope. The tetrameric BT-MAP was highly immunogenic, eliciting murine and rabbit antisera which reacted strongly in ELISA with peptides, and not only with OM from the homologous subtype P1.16b strain, but also with OM from the subtype P1.16a strain. The immunogenicity of BT-MAP may be due to a combination of factors. First, amino acid residues located at the N terminus and distal to the core matrix are usually the most antigenic, due to greater flexibility and accessibility (Lu e t al., 1991) . Also, since the density of the Th-cell epitope determines the concentration of the MHC-epitope on the surface of the antigen-processing cell, a large number of MHC proteins displaying their epitope simultaneously may amplify the subsequent T and B lymphocyte activation, proliferation and differentiation processes (Esposito e t al., 1993) . Structural studies have also shown that the synthesis of a lOmer T-cell epitope on a tetrameric MAP stabilizes peptide conformation, leading to an enhancement in the T-cell proliferation response (Esposito e t al., 1993) .
The specificity of antisera raised in mice and rabbits to peptide BT-MAP was also confirmed by epitope mapping. Antisera reacted specifically with the meningococcal P1.16b subtype B-cell epitope (180TKNTNNNLTL1s9), and also cross-reacted equally well with the P1.16a subtype. Therefore, immunization with BT-MAP induced polyclonal antisera which, in contrast to the P1.16 mAbs (McGuinness e t al., 1993) , reacted with peptides containing a minor variation in the subtype epitope. A surprising finding in this study was that both murine and rabbit antisera raised against BT-MAP did not react with the class 1 protein in Western blots. Antisera to synthetic peptides contain antibodies directed towards conformational and non-conformational structures adopted by the peptide. Since MAP peptides may be constrained in some manner, this would favour the predominance of con-formational antibodies which may not react with denatured proteins in Western blots. However, these antisera also reacted strongly with linear peptides in ELISA and on polyethylene pins. A possible explanation for non-reactivity with the denatured proteins may be that solid-phase assays with peptides detect a low proportion of non-conformational antibodies which cannot be detected in Western blots, possibly because of a lower molar amount of available epitope in the immunoblotted proteins and the reduced sensitivity of the assay. It is generally accepted that immunity to meningococcal infection correlates with bactericidal activity in vitrc (Goldschneider e t al., 1969) , so that any candidate group B meningococcal vaccine must have the ability to induct. an effective complement-mediated bactericidal responsc: (Frasch, 1985) . Thus, the most important property of the antisera raised during the current study is that antisera from rabbits immunized with peptide BT-MAP were highly bactericidal for the homologous subtype P1.161) strain, MC58. Furthermore, these antisera also recognizetl and promoted bactericidal killing of the heterologou s Pl.lba strain, MC50. Thus, in contrast with the Pl.16-specific mAbs (McGuinness e t al., 1993) , the polyclonal response to the BT-MAP is such that the protective effect is extended to a strain which shows an important variation within the subtype epitope. Since minor variations within subtype epitopes appear to be relatively common (Feavers e t al., 1992; McGuinness et al., 1993) , such a crossprotective effect would be an important property for a potential vaccine antigen. Despite the specificity cf reactivity of antisera with OMS in ELISA, no unequivocal correlation could be drawn between the bactericidxl activity of rabbit antisera for meningococci and the observed increases in O M titres. This finding is in accord with the conclusion of the previous study with cyclic peptides, that ELISA O M assays are not reliable indicators of protection, and reinforces further the importance of relevant biological assays such as bactericidal killing (Christodoulides e t a/., 1993). Although rabbit and murine antisera raised to peptides BT and BT-MAP showed similar reactivities in ELIS4 and epitope mapping experiments, in contrast to rabbit antisera, murine antisera did not induce complementmediated bactericidal killing of meningococci in vitro. Bactericidal activity is dependent not only on the amount, epitope specificity and high avidity of antibodies induced, but also on the class and ratio of complement-activating to non-complement-activating antibodies (Verheul e t a!., 1993) . Murine antibodies of subclasses IgG2a, IgG2 b, IgG3 and IgM are effective activators of complement, whereas IgA and I g G l display little or no activity, with the latter also capable of inhibiting complement-activating antibodies (Ey etal., 1980; Neuberger & Rajewsky, 1981) . The fact that murine antisera did not kill meningococci in the presence of complement may be in accord with the observation that IgGl antibodies are also the predominant isotype induced in Balb/C mice by immunization with Freund's adjuvant (Hadjipetrou-Kourounakis & Moller, 1 984). In humans, immunization with a synthetic peptide immunogen must induce antibodies that are cross-reactive with the epitope in its native conformation. Also, the use of alternative non-toxic adjuvants with these peptide immunogens is essential, since Freund's adjuvant is unacceptable for human immunization. It is desirable that these non-toxic adjuvants preferentially elicit high-affinity antibodies of the correct isotypes which are effective in activating complement and so conferring protection. In addition, the humoral response is dependent on the presence of Th-cell epitopes which can be recognized promiscuously by human MHC class I1 molecules. Although a human tetanus toxin Th-cell epitope would be expected to induce an immune response in human vaccinees, it would not trigger specific meningococcal Tcell memory in immunized individuals who subsequently encounter meningococcal infection. Recently, Th-cell epitopes have been identified within the class 1 protein of N. meningitidis which are recognized by immune humans (Wiertz et al., 1992) . Thus, information is now available which would permit the design of vaccines to include a protective meningococcal B-cell epitope together with Th-cell epitopes, recognized promiscuously by human MHC class I1 molecules. Certainly, the observation that a MAP containing defined B-and Th-cell epitopes induces a bactericidal response against group B meningococci, demonstrates the potential of such synthetic antigens as components of new meningococcal vaccines. 
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